Research suggests that intrinsic rb activation may induce anti-tumor responses in triple-negative breast cancer, potentially limiting the disease. The tumor microenvironment and interactions between tumor and stromal cells appear to play a role in shaping the immune landscape and influencing treatment outcomes. The relationship between these factors and immunotherapy is being explored, with studies investigating various mechanisms, including lipid metabolism reprogramming and overcoming t cell exhaustion.